National Oxygen Board Approves Share Sale to Promoter Group

National Oxygen Limited's board of directors has approved selling up to 950,000 equity shares, each with a face value of ₹10, to Saraf Housing Development Private Limited, a promoter group entity. A registered valuer will determine the issue price for these shares, in line with SEBI regulations.

The decision was made during a board meeting on March 20, 2026. The proposed allotment involves up to 950,000 equity shares, each carrying a face value of ₹10. These shares are designated for Saraf Housing Development Private Limited, which is part of the company's promoter group. An independent registered valuer has been appointed to establish the final price.

Implications for Shareholders and Promoters

This share sale is intended to raise capital for National Oxygen, which could bolster its financial position. For current shareholders, it means the total number of shares will increase, potentially diluting their ownership percentage. The involvement of a promoter entity suggests an effort to strengthen the promoter's stake or secure strategic investment.

Company Background and Recent Performance

Founded in 1974, National Oxygen Limited is a producer and supplier of industrial gases such as oxygen and nitrogen. Saraf Housing Development Private Limited shares management links with National Oxygen, including common directors such as Rajesh Kumar Saraf, who serves as National Oxygen's Managing Director.

The company's stock has drawn scrutiny from stock exchanges previously, leading to requests for clarification on notable price swings. National Oxygen has faced recent financial difficulties, reporting losses and a downward trend in revenue.

Expected Outcomes of the Capital Raise

Once the share allotment is complete, National Oxygen expects to receive capital from Saraf Housing Development. The promoter group's stake in the company may grow depending on the final number of shares allocated. This capital infusion could be directed towards improving operations or covering financial gaps.

Key Risks and Considerations

A key risk involves the registered valuer setting a fair price for the shares that benefits both National Oxygen and its existing shareholders. The company's overall financial health continues to be a concern, with recent reports showing losses and falling revenues. The preferential share issue will also require necessary regulatory approvals before it can be finalized.

Industry Landscape

In the industrial gases sector, National Oxygen Limited competes with larger players such as market leader Linde India, along with companies like Refex Industries Ltd. and Ellenbarrie Industrial Gases Ltd. National Oxygen is a smaller participant compared to these peers.

Recent Share Performance

As of March 19, 2026, National Oxygen's share price had fallen by 41.42% over the past year.

Future Focus for Investors

Investors will be watching for the final price set by the registered valuer, the completion of approvals from SEBI and stock exchanges, and how the company's financial health and operations perform after the capital infusion. Any updates on how the raised funds will be used will also be significant.